Solitary fibrous tumor of the dura

Changed by Yaïr Glick, 15 Jul 2022
Disclosures - updated 4 May 2022: Nothing to disclose

Updates to Article Attributes

Body was changed:

Solitary fibrous tumours of the dura are rare dural masses, histologically identical to solitary fibrous tumours found elsewhere and encompassing haemangiopericytomas (previously thought of as separate diagnoses). This is reflected in the current WHO classification of CNS tumours.

Solitary fibrous tumours are composed of spindle cells thought to be of mesenchymal origin. They usually occur in middle-aged individuals and symptoms depend on the size of the mass and its location.

On imaging, these tumours are similar to meningiomas, appearing as extra-axial well-circumscribed solid masses with vivid contrast enhancement. 

Epidemiology

Solitary fibrous tumours occur in older middle-aged individuals (mean age: 47-56 years of age), without a convincing gender predilection, although some reports have found increased incidence in females 1,2

Clinical presentation

Clinical presentation is nonspecific and identical to other dural masses (e.g. meningioma). Symptoms depend on the size of the mass and its location. Headache is the most common presenting complaint 1

Rarely, solitary fibrous tumours result in non-islet cell tumour hypoglycaemia (NICTH) as a result of secretion of insulin-like growth factor-2 (IGF-2) 3. Rarer still is acromegaly 3

Pathology

Grading

Although this is an area of some debate with alternative grading systems having been proposed, usually, solitary fibrous tumours of the dura can be graded from WHO grade 1 to grade 3; what was previously known as haemangiopericytomas representing WHO grade 2 or 3 tumours) 5,9

Macroscopic appearance

These are well-circumscribed and firm 5

Microscopic appearance

Typically, solitary fibrous tumours demonstrate areas thick bands of collagen separating areas of hypercellularity and hypocellularity. Staghorn vessels, classically seen in haemangiopericytomas, are also commonly seen 5

Immunophenotype

The immunohistochemical appearance of solitary fibrous tumours is characterised by 1,2,5:

  • CD34: positive
  • vimentin: positive
  • STAT6 protein: relocation of this protein to the nucleus
  • EMA: usually negative
  • PS100: negative
Genotype
  • genomic inversion of 12q13 locus resulting in the fusion of NAB2 and STAT6 genes 5

Radiographic features

The radiographic appearances are those of a well-circumscribed mass arising from the dura (supratentorial convexity, falx and tentorium and posterior fossa). Unlike solitary fibrous tumours of the spinal cord, which most frequently arise from the cord itself and not the theca 2, parenchymal tumours of the brain are very rare.

CT

Solitary fibrous tumours are well-circumscribed and isodense to hyperdense compared to adjacent brain. They may demonstrate calcifications and may erode bone if abutting it 1

MRI

These tumours are similar to meningiomas, appearing as extra-axial well-circumscribed masses, with the following signal characteristics 1,2

  • T1
    • typically, intermediate signal similar to brain
  • T2
    • iso- to hypointensity (the best clue to the diagnosis)
    • heterogeneous signal: "yin-yang" appearance of separate areas with low signal and high signal intensity may be characteristic 6,7,8
    • flow voids commonly seen
  • T1 C+
    • vivid diffuse heterogeneous contrast enhancement of low T2 signal components
    • dural tail may be seen, but is much less common than in meningiomas
  • DWI / ADC: regions of restricted diffusion are frequently seen
  • MRS
  • MR perfusion: elevated rCBV
Angiography

Prominent tumour blush, with feeding vessels varying, depending on the location of the tumour. Importantly, in addition to meningeal supply, these tumours can receive blood supply from pial vessels 1.

Treatment and prognosis

Surgical resection, if complete, is usually curative. Recurrence rates are variably reported as low to relatively high; up to 50% in one series 2. If incomplete or recurrence occurs, then radiotherapy may be employed 1

Differential diagnosis

The differential of solitary fibrous tumours of the dura is essentially that of other dural masses, and common entities to be considered include 1,2

The most useful feature that helps in making a preoperative diagnosis is the propensity for low grade solitary fibrous tumour to be low signal on T2.

Importantly, lymphoma, Erdheim-Chester disease and melanocytic lesions may also have low T2 signal. Meningiomas may also be low on T2, usually in the setting of mineralisation/calcification; thus reviewing other sequences (T2*) or CT is useful. 

  • -<p><strong>Solitary fibrous tumours of the dura</strong> are rare <a href="/articles/dural-masses">dural masses</a>, histologically identical to <a href="/articles/solitary-fibrous-tumour">solitary fibrous tumours</a> found elsewhere and encompassing <a href="/articles/meningeal-haemangiopericytoma-historical">haemangiopericytomas</a> (previously thought of as separate diagnoses). This is reflected in the current <a href="/articles/who-classification-of-cns-tumours-1">WHO classification of CNS tumours</a>.</p><p>Solitary fibrous tumours are composed of spindle cells thought to be of mesenchymal origin. They usually occur in middle-aged individuals and symptoms depend on the size of the mass and its location.</p><p>On imaging, these tumours are similar to meningiomas, appearing as extra-axial well-circumscribed solid masses with vivid contrast enhancement. </p><h4>Epidemiology</h4><p>Solitary fibrous tumours occur in older middle-aged individuals (mean 47-56 years of age), without a convincing gender predilection, although some reports have found increased incidence in females <sup>1,2</sup>. </p><h4>Clinical presentation</h4><p>Clinical presentation is nonspecific and identical to other dural masses (e.g. <a href="/articles/meningioma">meningioma</a>). Symptoms depend on the size of the mass and its location. Headache is the most common presenting complaint <sup>1</sup>. </p><p>Rarely, solitary fibrous tumours result in <a href="/articles/non-islet-cell-tumor-hypoglycemia-nicth">non-islet cell tumour hypoglycaemia (NICTH)</a> as a result of secretion of insulin-like growth factor-2 (IGF-2) <sup>3</sup>. Rarer still is <a href="/articles/acromegaly">acromegaly</a> <sup>3</sup>. </p><h4>Pathology</h4><h5>Grading</h5><p>Although this is an area of some debate with alternative grading systems having been proposed, usually, solitary fibrous tumours of the dura can be graded from WHO grade 1 to grade 3; what was previously known as haemangiopericytomas representing WHO grade 2 or 3 tumours) <sup>5,9</sup>. </p><h5>Macroscopic appearance</h5><p>These are well-circumscribed and firm <sup>5</sup>. </p><h5>Microscopic appearance</h5><p>Typically, solitary fibrous tumours demonstrate areas thick bands of collagen separating areas of hypercellularity and hypocellularity. <a href="/articles/staghorn-pattern-of-vascularity">Staghorn vessels</a>, classically seen in haemangiopericytomas, are also commonly seen <sup>5</sup>. </p><h5>Immunophenotype</h5><p>The immunohistochemical appearance of solitary fibrous tumours is characterised by <sup>1,2,5</sup>:</p><ul>
  • +<p><strong>Solitary fibrous tumours of the dura</strong> are rare <a href="/articles/dural-masses">dural masses</a>, histologically identical to <a href="/articles/solitary-fibrous-tumour">solitary fibrous tumours</a> found elsewhere and encompassing <a href="/articles/meningeal-haemangiopericytoma-historical">haemangiopericytomas</a> (previously thought of as separate diagnoses). This is reflected in the current <a href="/articles/who-classification-of-cns-tumours-1">WHO classification of CNS tumours</a>.</p><p>Solitary fibrous tumours are composed of spindle cells thought to be of mesenchymal origin. They usually occur in middle-aged individuals and symptoms depend on the size of the mass and its location.</p><p>On imaging, these tumours are similar to meningiomas, appearing as extra-axial well-circumscribed solid masses with vivid contrast enhancement. </p><h4>Epidemiology</h4><p>Solitary fibrous tumours occur in older middle-aged individuals (mean age: 47-56 years), without a convincing gender predilection, although some reports have found increased incidence in females <sup>1,2</sup>. </p><h4>Clinical presentation</h4><p>Clinical presentation is nonspecific and identical to other dural masses (e.g. <a href="/articles/meningioma">meningioma</a>). Symptoms depend on the size of the mass and its location. Headache is the most common presenting complaint <sup>1</sup>. </p><p>Rarely, solitary fibrous tumours result in <a href="/articles/non-islet-cell-tumor-hypoglycemia-nicth">non-islet cell tumour hypoglycaemia (NICTH)</a> as a result of secretion of insulin-like growth factor-2 (IGF-2) <sup>3</sup>. Rarer still is <a href="/articles/acromegaly">acromegaly</a> <sup>3</sup>. </p><h4>Pathology</h4><h5>Grading</h5><p>Although this is an area of some debate with alternative grading systems having been proposed, usually, solitary fibrous tumours of the dura can be graded from WHO grade 1 to grade 3; what was previously known as haemangiopericytomas representing WHO grade 2 or 3 tumours) <sup>5,9</sup>. </p><h5>Macroscopic appearance</h5><p>These are well-circumscribed and firm <sup>5</sup>. </p><h5>Microscopic appearance</h5><p>Typically, solitary fibrous tumours demonstrate areas thick bands of collagen separating areas of hypercellularity and hypocellularity. <a href="/articles/staghorn-pattern-of-vascularity">Staghorn vessels</a>, classically seen in haemangiopericytomas, are also commonly seen <sup>5</sup>. </p><h5>Immunophenotype</h5><p>The immunohistochemical appearance of solitary fibrous tumours is characterised by <sup>1,2,5</sup>:</p><ul>
Images Changes:

Image 5 MRI (T1 C+) ( create )

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.